Carboplatin or Docetaxel in Treating Women With Metastatic Genetic Breast Cancer

NCT00321633 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

148

Enrollment

OTHER

Sponsor class

Conditions

brca1 Mutation Carrier
brca2 Mutation Carrier
Breast Cancer
Hereditary Breast/Ovarian Cancer (brca1, brca2)

Interventions

DRUG: carboplatin
DRUG: docetaxel

Sponsor

University College London Hospitals